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EoE is a global health condition, with an incidence of ~1
per 10,000 people in the US. Symptoms of EoE greatly
impar quality of life. Individuals with EoE are predomi-
nantly young males with a high rate of atopic disease,
and the diagnosis of EoE is made by endoscopy and
biopsy findings of isolated eosinophils in the esophagus.
Although the underlying cause remains unknown, EoE
as other atopic diseases is recognized as complex genetic
disorders, where multiple genes interact with each other
and with the environment to trigger variable expression
of the atopic phenotype. Accumulating evidence sug-
gests that EoE has a strong familial association. Molecu-
lar analysis of esophageal biopsies and mouse models
have indicated a clear role for the T helper 2 pathway,
in particular interleukins 5 and 13, in this disease. In
recent years, the genetics of atopy, asthma and EoE have
been investigated using genome-wide linkage analyses
and candidate gene association studies. Using such
approach a single-nucleotide polymorphism (SNP) in
the human eotaxin-3 gene has been found to be asso-
ciated with EoE in about 15% of the patients. Such
research approach in EoE as in atopy and asthma, while
providing certain valuable insights into the genetics of
atopic diseases, has achieved only limited success in
identifying the genetic determinants of these related dis-
orders. More recently, however, critical information
provided by the Human Genome Project and the Inter-
national HapMap Project has prompted the develop-
ment of unprecedented genotyping technology and tools
such as genome-wide association (GWA) studies to
more comprehensively investigate the genetic basis of
complex diseases such as atopy and EoE. In the past
year, such research approach has led to the identifica-
tion of single nucleotide polymorphisms in the gene
encoding thymic stromal lymphopoietin (TSLP), and
subsequently in the gene encoding its receptor, as dis-
ease susceptibility markers for EoE. Identification of this
molecule and its receptor suggest the potential for new
treatment options in the future.
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